These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29302645)

  • 1. COMMUNITY ACQUIRED PNEUMOCOCCAL PNEUMONIA IN NORTHWESTERN NIGERIA: EPIDEMIOLOGY, ANTIMICROBIAL RESISTANCE AND OUTCOME.
    Iliyasu G; Mohammad FD; Habib AG
    Afr J Infect Dis; 2018; 12(1):15-19. PubMed ID: 29302645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Susceptibility Pattern of Invasive Pneumococcal Isolates in North West Nigeria.
    Lliyasu G; Habib AG; Mohammad AB
    J Glob Infect Dis; 2015; 7(2):70-4. PubMed ID: 26069426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complications of community acquired pneumonia on the outcome of the illness: a prospective observational study in a tertiary institution in eastern Nigeria.
    Mbata G; Chukwuka C; Onyedum C; Onwubere B; Aguwa E
    Ann Med Health Sci Res; 2013 Jul; 3(3):365-9. PubMed ID: 24116315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
    Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
    PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study.
    Krueger P; St Amant O; Loeb M
    BMC Geriatr; 2010 Jun; 10():44. PubMed ID: 20591180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study.
    Mongardon N; Max A; Bouglé A; Pène F; Lemiale V; Charpentier J; Cariou A; Chiche JD; Bedos JP; Mira JP
    Crit Care; 2012 Aug; 16(4):R155. PubMed ID: 22894879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of in-hospital mortality and length of stay in community-acquired pneumonia: a 5-year multi-centre case control study of adults in a developing country.
    Iroezindu MO; Isiguzo GC; Chima EI; Mbata GC; Onyedibe KI; Onyedum CC; John-Maduagwu OJ; Okoli LE; Young EE
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):445-55. PubMed ID: 27618923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CURB-65 scoring system in severity assessment of Eastern Nigerian patients with community-acquired pneumonia: a prospective observational study.
    Mbata GC; Chukwuka CJ; Onyedum CC; Onwubere BJ
    Prim Care Respir J; 2013 Jun; 22(2):175-80. PubMed ID: 23633130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines.
    Heo JY; Seo YB; Jeong HW; Choi MJ; Min KH; Choi WS; Lee J; Noh JY; Cheong HJ; Kim WJ; Song JY
    Vaccine; 2020 Nov; 38(49):7747-7755. PubMed ID: 33164798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
    Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
    Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community acquired pneumonia among pediatric outpatients in Salvador, Northeast Brazil, with emphasis on the role of pneumococcus.
    Nascimento-Carvalho CM; Lopes AA; Gomes MD; Magalhães MP; Oliveira JR; Vilas-Boas AL; Ferracuti R; Brandileone MC; Guerra ML; Alves NN; Athayde LA; Caldas RM; Barberino MG; Duarte J; Brandão MA; Rocha H; Benguigui Y; Di Fabio JL
    Braz J Infect Dis; 2001 Feb; 5(1):13-20. PubMed ID: 11290310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia.
    Georges H; Leroy O; Vandenbussche C; Guery B; Alfandari S; Tronchon L; Beaucaire G
    Intensive Care Med; 1999 Feb; 25(2):198-206. PubMed ID: 10193548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
    Walters JA; Tang JN; Poole P; Wood-Baker R
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001390. PubMed ID: 28116747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation.
    Demirdogen Cetinoglu E; Uzaslan E; Sayıner A; Cilli A; Kılınc O; Sakar Coskun A; Hazar A; Kokturk N; Filiz A; Polatli M;
    Hum Vaccin Immunother; 2017 Sep; 13(9):2072-2077. PubMed ID: 28708954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia.
    Cillóniz C; Liapikou A; Martin-Loeches I; García-Vidal C; Gabarrús A; Ceccato A; Magdaleno D; Mensa J; Marco F; Torres A
    PLoS One; 2018; 13(7):e0200504. PubMed ID: 30020995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
    Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
    Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
    Gessner BD; Jiang Q; Van Werkhoven CH; Sings HL; Webber C; Scott D; Gruber WC; Grobbee DE; Bonten MJM; Jodar L
    Vaccine; 2019 Jul; 37(30):4147-4154. PubMed ID: 31155413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
    Torres A; Cillóniz C; Blasi F; Chalmers JD; Gaillat J; Dartois N; Schmitt HJ; Welte T
    Respir Med; 2018 Apr; 137():6-13. PubMed ID: 29605214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe pneumococcal community-acquired pneumonia admitted to medical Tunisian ICU.
    Belkhouja K; Ben Romdhane K; Ghariani A; Hammami A; M'hiri E; Slim-Saidi L; Ben Khelil J; Besbes M
    J Infect Chemother; 2012 Jun; 18(3):324-31. PubMed ID: 22045164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.